Pier Capital’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,127,773
| Closed | -$6.15M | – | 123 |
|
|
2024
Q4 | $6.15M | Buy |
1,127,773
+651,921
| +137% | +$3.55M | 0.88% | 71 |
|
|
2024
Q3 | $3.95M | Sell |
475,852
-2,503
| -0.5% | -$20.8K | 0.56% | 93 |
|
|
2024
Q2 | $3.43M | Sell |
478,355
-27,940
| -6% | -$200K | 0.51% | 90 |
|
|
2024
Q1 | $4.39M | Buy |
506,295
+219,446
| +77% | +$1.9M | 0.6% | 77 |
|
|
2023
Q4 | $1.88M | Sell |
286,849
-3,714
| -1% | -$24.3K | 0.27% | 93 |
|
|
2023
Q3 | $2.91M | Sell |
290,563
-5,487
| -2% | -$54.9K | 0.47% | 88 |
|
|
2023
Q2 | $3.68M | Sell |
296,050
-5,298
| -2% | -$65.9K | 0.53% | 90 |
|
|
2023
Q1 | $4.22M | Buy |
301,348
+29,193
| +11% | +$409K | 0.64% | 78 |
|
|
2022
Q4 | $3.89M | Buy |
272,155
+254,314
| +1,425% | +$3.64M | 0.64% | 76 |
|
|
2022
Q3 | $455K | Sell |
17,841
-13,785
| -44% | -$352K | 0.08% | 96 |
|
|
2022
Q2 | $898K | Buy |
31,626
+12,244
| +63% | +$348K | 0.15% | 90 |
|
|
2022
Q1 | $684K | Buy |
19,382
+9,014
| +87% | +$318K | 0.09% | 98 |
|
|
2021
Q4 | $434K | Buy |
+10,368
| New | +$434K | 0.05% | 107 |
|